Update RequiredTo play the media you will need to either update your browser to a recent version or update your Flash plugin.
Update RequiredTo play the media you will need to either update your browser to a recent version or update your Flash plugin.
Update RequiredTo play the media you will need to either update your browser to a recent version or update your Flash plugin.
Update RequiredTo play the media you will need to either update your browser to a recent version or update your Flash plugin.
Update RequiredTo play the media you will need to either update your browser to a recent version or update your Flash plugin.
Author(s)
Deborah Arnott, Andrew Black, Robert West, Linda Bauld and Jeremy Mean
Presenter(s)
Andrew Black Tobacco Programme Manager, Department of Health
Professor Robert West Professor of Health Psychology and Director of Tobacco Studies, Cancer Research UK Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London
Professor Linda Bauld Professor of Socio-Management, School of Management, University of Stirling
Jeremy Mean Access and Information for Medicines and Standards Group Manager, Vigilance and Risk Management of Medicines Division (VRMM), Medicines and Healthcare Products Regulatory Agency
Michell Zeller Vice President for Policy and Strategic Communications, Pinney Associates and Visiting Scientist, Harvard University School of Public Health, USA
Biography
Deborah Arnott has been chief executive of ASH and a member of the RCP Tobacco Advisory Group since 2003. She is an honorary Associate Professor in the Division of Epidemiology and Public Health University of Nottingham, and was a member of the Commission on Human Medicines working group on harm reduction and NRT. She is an international expert on tobacco control, with particular reference to the WHO Framework Convention on Tobacco Control. She was awarded the Alwyn Smith prize in 2007 by the Faculty of Public Health for her outstanding contribution to public health.
Andrew Black is the Tobacco Programme Manager at the Department of Health.
Robert West is Professor of Health Psychology and Director of Tobacco Studies at the Cancer Research UK Health Behaviour Research Centre of University College London. Dr West is the Editor-in-Chief of Addiction. He has published some 300 scientific works and is coauthor of the English and Scottish National Smoking Cessation Guidelines that provided the blueprint for the UK-wide network of NHS smoking-cessation services. He is also co-director of the NHS Centre for Smoking Cessation and Training, funded by the Department of Health and President of the Society for Research in Nicotine and Tobacco.
Linda Bauld is a Professor in the School of Management at the University of Stirling. Her primary research interests are in the evaluation of public health interventions and the relationship between evidence and policy. She conducted the first study of NHS stop smoking services when they were established in 1999 and since then has continued to work with the services on research, training and advocacy projects. From 2007 to 2010 she served as the Department of Health's scientific adviser on tobacco control and has recently been appointed to chair the programme development group on tobacco harm reduction for NICE.
Jeremy Mean is the Access and Information for Medicines and Standards Group Manager in the Vigilance and Risk Management of Medicines Division (VRMM) of the UKs Medicines and Healthcare products Regulatory Agency. Jeremy is a career civil servant, having joined the service in 1984, and has worked in a succession of policy and management posts in the MHRA and in the Department of Health.
Mitchell Zeller, J.D. is Vice President for Policy and Strategic Communications, Pinney Associates; Visiting Scientist, Harvard University School of Public Health; Professorial Lecturer, American University School of Law. He has 28 years of regulatory, legislative, and communications experience working with federal health agencies on public health policy issues including the treatment of tobacco dependence, and the regulation of tobacco products, pharmaceuticals, and other FDA-regulated products. From 1993 until June 2000, Zeller served as associate commissioner and director of the Food and Drug Administration's (FDA) Office of Tobacco Programs. He served as the FDA's representative on tobacco issues in all dealings with the Congress, federal and state agencies, public health groups and foreign governments.
